<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82811">
  <stage>Registered</stage>
  <submitdate>9/05/2008</submitdate>
  <approvaldate>8/05/2009</approvaldate>
  <actrnumber>ACTRN12609000228280</actrnumber>
  <trial_identification>
    <studytitle>Randomised Controlled Trial of Cognitive Behaviour Therapy for Reduction in Posttraumatic Stress Disorder (PTSD) Symptoms</studytitle>
    <scientifictitle>Randomised Controlled Trial of Cognitive Behaviour Therapy for Reduction in Posttraumatic Stress Disorder (PTSD) Symptoms After Exposure to Any Traumatic Event</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Posttraumatic Stress Disorder</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Anxiety</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Modified Cognitive Behaviour Therapy involves 12 once-weekly 90-minute sessions of individual therapy over 12 weeks.  The therapy includes brief reliving of trauma memories (5 minute duration) integrated with re-appraisals of beliefs of the trauma experience.  The duration of the study for any participant will conclude after the 6-month follow-up assessment, resulting in participation duration of 9 months.</interventions>
    <comparator>Cognitive Behaviour Therapy involves 12 once-weekly 90-minute sessions of individual therapy over 12 weeks.  The therapy includes prolonged reliving of trauma memories (40 minute duration) integrated with re-appraisals of beliefs of the trauma experience.  The duration of the study for any patient will conclude after the 6-month follow-up assessment, resulting in participation duration of 9 months.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Posttraumatic stress disorder as measured by the Clinician Administered Posttraumatic Stress Disorder (PTSD) Scale</outcome>
      <timepoint>Pretreatment, Posttreatment, 6-Month Follow-Up</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Depression as measured by the Beck Depression Inventory</outcome>
      <timepoint>Pretreatment, Posttreatment, 6-Month Follow-Up</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>(1) Exposure to trauma, (2) Meet criteria for PTSD</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Suicidal intent, psychotic, substance dependent</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Participants will be treatment seeking patients attending the Traumatic Stress Clinic at Westmead Hospital.  Participants will be randomly assigned according to a random numbers system administered by an individual who is independent of the study and who works at a site that is distant from the treatment center.</concealment>
    <sequence>Randomization will be conducted by a process of minimization stratified on gender, trauma type, and Posttraumatic Stress Disorder severity.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/06/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>70</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of New South Wales</primarysponsorname>
    <primarysponsoraddress>University of New South Wales
Sydney, NSW, 2052</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>National Health &amp; Medical Research Council</fundingname>
      <fundingaddress>School of Psychology
University of New South Wales
Sydney, NSW, 2052</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Westmead Hospital</sponsorname>
      <sponsoraddress>Westmead Hospital
O'Briens Road
Westmead,  NSW,  2145</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study will randomly allocate patients with PTSD to either standard cognitive behaviour therapy (CBT) or to cognitive behaviour therapy (CBT) that does not provide prolonged exposure.  Instead, the cognitive behaviour therapy (CBT) will include brief exposures to trauma memories integrated with cognitive restructuring.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Sydney West Area Health Service Human Ethics Committee</ethicname>
      <ethicaddress>Westmead Hospital
O'Briens Road
Westmead,  NSW,  2145</ethicaddress>
      <ethicapprovaldate>12/02/2007</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Professor Richard Bryant</name>
      <address>School of Psychology
University of New South Wales
Sydney, NSW,  2052</address>
      <phone>61-2-93853640</phone>
      <fax>61-2-93853641</fax>
      <email>r.bryant@unsw.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Professor Richard Bryant</name>
      <address>School of Psychology
University of New South Wales
Sydney, NSW,  2052</address>
      <phone>61-2-93853640</phone>
      <fax>61-2-93853641</fax>
      <email>r.bryant@unsw.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Professor Richard Bryant</name>
      <address>School of Psychology
University of New South Wales
Sydney, NSW,  2052</address>
      <phone>61-2-93853640</phone>
      <fax>61-2-93853641</fax>
      <email>r.bryant@unsw.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>